体液採取と診断の世界市場

体液採取と診断の世界市場は2030年までに463億米ドルに達する見込み

2024年に333億米ドルと推定される体液採取と診断の世界市場は、2024年から2030年にかけてCAGR 5.6%で成長し、2030年には463億米ドルに達すると予測されます。本レポートで分析されているセグメントの一つである血液サンプルは、CAGR6.4%を記録し、分析期間終了までに210億米ドルに達すると予測されています。唾液サンプルセグメントの成長率は、分析期間中CAGR 5.3%と推定されます。

米国市場は91億米ドルと推定、中国はCAGR9.0%で成長予測

米国の体液採取と診断市場は2024年に91億米ドルと推定されます。世界第2位の経済大国である中国は、2024～2030年の分析期間においてCAGR 9.0％を辿り、2030年までに94億米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ2.7%と5.6%と予測されています。欧州では、ドイツがCAGR 3.7%で成長すると予測されています。

世界の体液採取と診断市場- 主要動向と促進要因のまとめ

体液採取と診断を変革する技術革新とは？

体液採取と診断市場は、診断精度、効率性、患者の快適性を向上させる技術的進歩により、急速な変革を遂げつつあります。マイクロ流体工学とラボオンチップ技術の革新は、体液の分析方法に革命をもたらし、最小限のサンプル量で迅速なポイントオブケア診断を可能にしました。自動サンプル採取装置とクローズド・ループ・システムは、汚染や感染物質への曝露のリスクを低減し、安全性を向上させています。先進的なリキッドバイオプシー技術は、血液サンプルから循環腫瘍細胞（CTC）や無細胞DNA（cfDNA）の検出を可能にし、がん診断のための非侵襲的な選択肢として台頭してきています。リアルタイムポリメラーゼ連鎖反応（RT-PCR）や次世代シークエンシング（NGS）技術との分子診断学の統合により、病原体や遺伝子変異、さまざまな疾患に関連するバイオマーカーの検出が強化されつつあります。汗や間質液などの体液を連続的にモニタリングするウェアラブルデバイスが普及し、慢性疾患管理のためのリアルタイムの健康データを提供しています。さらに、特に感染症や生殖医療を対象とした在宅診断用自己採取キットの開発により、診断サービスへのアクセスが拡大しています。これらの技術革新は、診断能力を向上させ、所要時間を短縮し、正確なバイオマーカー分析を通じて個別化医療を可能にしています。

新たな健康動向と最終用途は体液診断市場をどのように拡大させているか？

体液採取と診断の需要は、新たな健康動向と疾病の早期発見への関心の高まりによって、幅広いヘルスケア用途で拡大しています。臨床現場では、体液分析は感染症、代謝異常、がんの診断に不可欠であり、その応用範囲は血液、尿、脳脊髄液、滑液診断にまで広がっています。COVID-19の大流行により、迅速診断検査や家庭用サンプル採取キットの普及が加速し、利用しやすく効率的な診断ソリューションの重要性が浮き彫りになりました。がん領域では、リキッドバイオプシー技術ががんのスクリーニングとモニタリングに革命をもたらし、腫瘍マーカーを検出し治療反応をモニタリングする非侵襲的な方法を提供しています。個別化医療や標的療法の台頭により、体液から特定の遺伝子変異やバイオマーカーを同定できる診断検査への需要が高まっています。さらに、スポーツ・フィットネス業界では、体液診断を活用して、水分補給レベル、電解質バランス、代謝マーカーをモニターし、パフォーマンスの最適化を図っています。製薬分野では、体液分析は臨床試験、医薬品開発、治療モニタリングにおいて重要な役割を果たしています。このように最終用途が多様化することで、体液診断の技術革新が促進され、世界の普及が進んでいます。

どのような規制や市場力学が体液採取と診断業界を形成しているのか？

体液採取と診断業界は、診断検査や採取装置の安全性、正確性、信頼性を保証するために設計された厳しい規制環境の中で運営されています。米国FDA、EMA、WHOなどの規制機関は、臨床的バリデーション、品質管理、市販後サーベイランスの要件を含む、診断薬の承認とモニタリングのための包括的ガイドラインを確立しています。診断の正確性と患者の安全性が重視されるようになったことで、サンプルの収集、取り扱い、分析に関する標準化されたプロトコルが採用されるようになりました。市場力学は、救急医療、遠隔地、在宅ヘルスケア環境における迅速診断の必要性に後押しされた、ポイントオブケア検査（POCT）に対する需要の高まりの影響を受けています。競合情勢は、製品ポートフォリオの拡大と技術力の強化を目的とした継続的な研究開発投資、戦略的提携、合併によって特徴付けられます。また、遠隔医療やデジタルヘルスプラットフォームの台頭により、患者が自宅で検体を採取し、電子的に結果を受け取ることができる遠隔診断の新たな機会が生まれています。保険償還政策や規制当局の承認経路は地域によって異なり、市場アクセスや採用率に影響を及ぼしています。こうした規制や市場の動向は、イノベーション、コンプライアンス、アクセシビリティを重視し、体液診断の将来を形成しています。

体液採取と診断市場の成長はいくつかの要因によって牽引される...

体液採取と診断市場の成長は、技術の進歩、慢性疾患の有病率の増加、疾患の早期発見への世界の注目など、いくつかの要因によって牽引されています。分子診断学、マイクロ流体工学、リキッドバイオプシー技術の革新は診断精度を高め、検出可能なバイオマーカーの範囲を拡大しています。COVID-19の大流行によって加速したポイントオブケア検査や在宅診断の需要の高まりは、迅速診断検査や自己採取キットの採用を増加させています。感染症、がん、代謝異常の負担の増大は、タイムリーな介入と個別化治療を可能にする包括的診断ソリューションの必要性を高めています。高度な診断技術に対する規制当局の支援は、ヘルスケア投資の増加とともに市場の成長を促進しています。さらに、遠隔医療サービスやデジタルヘルスプラットフォームの拡大により、特に遠隔地や十分なサービスを受けていない地域における診断検査へのアクセスが向上しています。診断薬企業、ヘルスケアプロバイダー、調査機関の戦略的提携は、イノベーションを促進し、市場リーチを拡大しています。これらの要因が、継続的な製品開拓、世界ヘルスイニシアチブ、予防ヘルスケアに対する意識の高まりと相まって、体液採取と診断市場を世界の持続的成長へと押し上げています。

セグメント

サンプルタイプ（血液サンプル、唾液サンプル、尿サンプル、脳脊髄液サンプル）、製品タイプ（キットおよび消耗品、機器、その他の検査／サービス）、技術タイプ（ポリメラーゼ連鎖反応、次世代シーケンシング、蛍光in situハイブリダイゼーション、その他の技術）、用途（診断およびモニタリング用途、治療意思決定用途、予後診断およびスクリーニング用途）

調査対象企業の例

• Abbott Laboratories, Inc.
• Becton, Dickinson and Company
• Biocept, Inc.
• BIOMAXIMA S.A.
• Bio-Rad Laboratories, Inc.
• CTK Biotech, Inc.
• F. Hoffmann-La Roche AG
• Guardant Health, Inc.
• Illumina, Inc.
• Johnson & Johnson Services, Inc.
• Laboratory Corporation of America Holdings
• Mdxhealth SA
• Qiagen, Inc.
• Seegene, Inc.
• Thermo Fisher Scientific, Inc.

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Body Fluid Collection and Diagnostics Market to Reach US$46.3 Billion by 2030

The global market for Body Fluid Collection and Diagnostics estimated at US$33.3 Billion in the year 2024, is expected to reach US$46.3 Billion by 2030, growing at a CAGR of 5.6% over the analysis period 2024-2030. Blood Samples, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$21.0 Billion by the end of the analysis period. Growth in the Saliva Samples segment is estimated at 5.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$9.1 Billion While China is Forecast to Grow at 9.0% CAGR

The Body Fluid Collection and Diagnostics market in the U.S. is estimated at US$9.1 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$9.4 Billion by the year 2030 trailing a CAGR of 9.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.7% and 5.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.7% CAGR.

Global Body Fluid Collection and Diagnostics Market - Key Trends & Drivers Summarized

What Are the Technological Innovations Transforming Body Fluid Collection and Diagnostics?

The body fluid collection and diagnostics market is undergoing rapid transformation, driven by technological advancements that enhance diagnostic accuracy, efficiency, and patient comfort. Innovations in microfluidics and lab-on-a-chip technologies have revolutionized the way body fluids are analyzed, allowing for rapid, point-of-care diagnostics with minimal sample volumes. Automated sample collection devices and closed-loop systems are improving safety by reducing the risk of contamination and exposure to infectious agents. Advanced liquid biopsy techniques are emerging as a non-invasive alternative for cancer diagnostics, enabling the detection of circulating tumor cells (CTCs) and cell-free DNA (cfDNA) from blood samples. Integration of molecular diagnostics with real-time polymerase chain reaction (RT-PCR) and next-generation sequencing (NGS) technologies is enhancing the detection of pathogens, genetic mutations, and biomarkers associated with various diseases. Wearable devices for continuous monitoring of body fluids such as sweat and interstitial fluid are gaining traction, providing real-time health data for chronic disease management. Additionally, the development of self-collection kits for home-based diagnostics, particularly for infectious diseases and reproductive health, is expanding access to diagnostic services. These technological innovations are improving diagnostic capabilities, reducing turnaround times, and enabling personalized medicine through precise biomarker analysis.

How Are Emerging Health Trends and End-Use Applications Expanding the Body Fluid Diagnostics Market?

The demand for body fluid collection and diagnostics is growing across a wide range of healthcare applications, driven by emerging health trends and the increasing focus on early disease detection. In clinical settings, body fluid analysis is essential for diagnosing infectious diseases, metabolic disorders, and cancers, with applications extending to blood, urine, cerebrospinal fluid, and synovial fluid diagnostics. The COVID-19 pandemic has accelerated the adoption of rapid diagnostic tests and home-based sample collection kits, highlighting the importance of accessible and efficient diagnostic solutions. In oncology, liquid biopsy techniques are revolutionizing cancer screening and monitoring, providing a non-invasive method to detect tumor markers and monitor treatment response. The rise of personalized medicine and targeted therapies has increased the demand for diagnostic tests that can identify specific genetic mutations and biomarkers from body fluids. Additionally, the sports and fitness industry is leveraging body fluid diagnostics to monitor hydration levels, electrolyte balance, and metabolic markers for performance optimization. In the pharmaceutical sector, body fluid analysis plays a critical role in clinical trials, drug development, and therapeutic monitoring. This diversification of end-use applications is driving innovation and expanding the global reach of body fluid diagnostics.

What Regulatory and Market Dynamics Are Shaping the Body Fluid Collection and Diagnostics Industry?

The body fluid collection and diagnostics industry operates within a stringent regulatory environment designed to ensure the safety, accuracy, and reliability of diagnostic tests and collection devices. Regulatory bodies such as the U.S. FDA, EMA, and WHO have established comprehensive guidelines for the approval and monitoring of diagnostic products, including requirements for clinical validation, quality control, and post-market surveillance. The increasing focus on diagnostic accuracy and patient safety has led to the adoption of standardized protocols for sample collection, handling, and analysis. Market dynamics are influenced by the growing demand for point-of-care testing (POCT), driven by the need for rapid diagnostics in emergency care, remote settings, and home healthcare environments. The competitive landscape is marked by continuous R&D investments, strategic partnerships, and mergers aimed at expanding product portfolios and enhancing technological capabilities. Additionally, the rise of telemedicine and digital health platforms has created new opportunities for remote diagnostics, enabling patients to collect samples at home and receive results electronically. Reimbursement policies and regulatory approval pathways vary across regions, influencing market access and adoption rates. These regulatory and market trends are shaping the future of body fluid diagnostics, emphasizing innovation, compliance, and accessibility.

The Growth in the Body Fluid Collection and Diagnostics Market Is Driven by Several Factors…

The growth in the body fluid collection and diagnostics market is driven by several factors, including technological advancements, increasing prevalence of chronic diseases, and the global focus on early disease detection. Innovations in molecular diagnostics, microfluidics, and liquid biopsy technologies are enhancing diagnostic accuracy and expanding the range of detectable biomarkers. The rising demand for point-of-care testing and home-based diagnostics, accelerated by the COVID-19 pandemic, has increased the adoption of rapid diagnostic tests and self-collection kits. The growing burden of infectious diseases, cancer, and metabolic disorders is driving the need for comprehensive diagnostic solutions that enable timely intervention and personalized treatment. Regulatory support for advanced diagnostic technologies, along with increasing healthcare investments, is facilitating market growth. Additionally, the expansion of telehealth services and digital health platforms is enhancing access to diagnostic testing, particularly in remote and underserved regions. Strategic collaborations between diagnostic companies, healthcare providers, and research institutions are fostering innovation and expanding market reach. These factors, combined with continuous product development, global health initiatives, and increasing awareness of preventive healthcare, are propelling the body fluid collection and diagnostics market toward sustained growth worldwide.

SCOPE OF STUDY:

The report analyzes the Body Fluid Collection and Diagnostics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Sample Type (Blood Samples, Saliva Samples, Urine Samples, Cerebrospinal Fluid Samples); Product Type (Kits and Consumables, Instruments, Other Tests/Services); Technology Type (Polymerase Chain Reaction, Next Generation Sequencing, Fluorescence In situ Hybridization, Other Technologies); Application (Diagnostics and Monitoring Application, Therapeutic Decision Making Application, Prognostics and Screening Application)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

• Abbott Laboratories, Inc.
• Becton, Dickinson and Company
• Biocept, Inc.
• BIOMAXIMA S.A.
• Bio-Rad Laboratories, Inc.
• CTK Biotech, Inc.
• F. Hoffmann-La Roche AG
• Guardant Health, Inc.
• Illumina, Inc.
• Johnson & Johnson Services, Inc.
• Laboratory Corporation of America Holdings
• Mdxhealth SA
• Qiagen, Inc.
• Seegene, Inc.
• Thermo Fisher Scientific, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Body Fluid Collection and Diagnostics - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Prevalence of Chronic Diseases and Infectious Conditions Drives Demand for Advanced Fluid Collection Technologies
  • Growing Emphasis on Early Disease Detection Propels Market for Rapid and Point-of-Care Diagnostic Solutions
  • Advancements in Microfluidics and Lab-on-a-Chip Technologies Transform Fluid Diagnostics Capabilities
  • Surging Demand for Home-Based and Self-Testing Kits Expands the Consumer Diagnostics Market
  • Integration of AI and Machine Learning in Fluid Sample Analysis Enhances Diagnostic Accuracy
  • Increasing Adoption of Liquid Biopsy for Cancer Detection Strengthens Market Growth Potential
  • Rising Global Focus on Pandemic Preparedness and Disease Surveillance Accelerates Innovations in Fluid Collection
  • Expansion of Personalized Medicine and Precision Diagnostics Spurs Demand for Advanced Biomarker Analysis
  • Miniaturization and Automation of Sample Processing Improve Speed and Efficiency in Diagnostics
  • Development of Smart Biosensors Enhances the Potential for Real-Time Health Monitoring
  • Surging Demand for Blood and Plasma Testing in Drug Development and Clinical Trials Expands Market Scope
  • Point-of-Care Testing (POCT) Growth in Emerging Markets Strengthens Business Case for Portable Fluid Diagnostics
  • Rising Awareness of Preventive Healthcare Spurs Market for Routine Fluid Analysis Tests
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Body Fluid Collection and Diagnostics Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Body Fluid Collection and Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Body Fluid Collection and Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Blood Samples by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Blood Samples by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Blood Samples by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Saliva Samples by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Saliva Samples by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Saliva Samples by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Urine Samples by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Urine Samples by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Urine Samples by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Cerebrospinal Fluid Samples by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Cerebrospinal Fluid Samples by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Cerebrospinal Fluid Samples by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Fluorescence In situ Hybridization by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Fluorescence In situ Hybridization by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Fluorescence In situ Hybridization by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Polymerase Chain Reaction by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Polymerase Chain Reaction by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Next Generation Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Next Generation Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Next Generation Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Diagnostics & Monitoring Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Diagnostics & Monitoring Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Diagnostics & Monitoring Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Therapeutic Decision Making Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Therapeutic Decision Making Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Therapeutic Decision Making Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Prognostics & Screening Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Prognostics & Screening Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Prognostics & Screening Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Kits & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Kits & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for Kits & Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: World 15-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 44: World Recent Past, Current & Future Analysis for Other Tests / Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 45: World Historic Review for Other Tests / Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: World 15-Year Perspective for Other Tests / Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Body Fluid Collection and Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 47: USA Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: USA 15-Year Perspective for Body Fluid Collection and Diagnostics by Sample Type - Percentage Breakdown of Value Sales for Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples for the Years 2015, 2025 & 2030
  • TABLE 50: USA Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: USA Historic Review for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: USA 15-Year Perspective for Body Fluid Collection and Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing for the Years 2015, 2025 & 2030
  • TABLE 53: USA Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: USA Historic Review for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: USA 15-Year Perspective for Body Fluid Collection and Diagnostics by Application - Percentage Breakdown of Value Sales for Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application for the Years 2015, 2025 & 2030
  • TABLE 56: USA Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: USA Historic Review for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: USA 15-Year Perspective for Body Fluid Collection and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Kits & Consumables, Instruments and Other Tests / Services for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 59: Canada Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Canada Historic Review for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: Canada 15-Year Perspective for Body Fluid Collection and Diagnostics by Sample Type - Percentage Breakdown of Value Sales for Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples for the Years 2015, 2025 & 2030
  • TABLE 62: Canada Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Canada Historic Review for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: Canada 15-Year Perspective for Body Fluid Collection and Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing for the Years 2015, 2025 & 2030
  • TABLE 65: Canada Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Canada Historic Review for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: Canada 15-Year Perspective for Body Fluid Collection and Diagnostics by Application - Percentage Breakdown of Value Sales for Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application for the Years 2015, 2025 & 2030
  • TABLE 68: Canada Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Canada Historic Review for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: Canada 15-Year Perspective for Body Fluid Collection and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Kits & Consumables, Instruments and Other Tests / Services for the Years 2015, 2025 & 2030
• JAPAN
  • Body Fluid Collection and Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 71: Japan Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Japan Historic Review for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: Japan 15-Year Perspective for Body Fluid Collection and Diagnostics by Sample Type - Percentage Breakdown of Value Sales for Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples for the Years 2015, 2025 & 2030
  • TABLE 74: Japan Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Japan Historic Review for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: Japan 15-Year Perspective for Body Fluid Collection and Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing for the Years 2015, 2025 & 2030
  • TABLE 77: Japan Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Japan Historic Review for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: Japan 15-Year Perspective for Body Fluid Collection and Diagnostics by Application - Percentage Breakdown of Value Sales for Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application for the Years 2015, 2025 & 2030
  • TABLE 80: Japan Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Japan Historic Review for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: Japan 15-Year Perspective for Body Fluid Collection and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Kits & Consumables, Instruments and Other Tests / Services for the Years 2015, 2025 & 2030
• CHINA
  • Body Fluid Collection and Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 83: China Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: China Historic Review for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: China 15-Year Perspective for Body Fluid Collection and Diagnostics by Sample Type - Percentage Breakdown of Value Sales for Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples for the Years 2015, 2025 & 2030
  • TABLE 86: China Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: China Historic Review for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: China 15-Year Perspective for Body Fluid Collection and Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing for the Years 2015, 2025 & 2030
  • TABLE 89: China Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: China Historic Review for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: China 15-Year Perspective for Body Fluid Collection and Diagnostics by Application - Percentage Breakdown of Value Sales for Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application for the Years 2015, 2025 & 2030
  • TABLE 92: China Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: China Historic Review for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: China 15-Year Perspective for Body Fluid Collection and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Kits & Consumables, Instruments and Other Tests / Services for the Years 2015, 2025 & 2030
• EUROPE
  • Body Fluid Collection and Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 95: Europe Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 96: Europe Historic Review for Body Fluid Collection and Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: Europe 15-Year Perspective for Body Fluid Collection and Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 98: Europe Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Europe Historic Review for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: Europe 15-Year Perspective for Body Fluid Collection and Diagnostics by Sample Type - Percentage Breakdown of Value Sales for Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples for the Years 2015, 2025 & 2030
  • TABLE 101: Europe Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Europe Historic Review for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: Europe 15-Year Perspective for Body Fluid Collection and Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing for the Years 2015, 2025 & 2030
  • TABLE 104: Europe Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Europe Historic Review for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: Europe 15-Year Perspective for Body Fluid Collection and Diagnostics by Application - Percentage Breakdown of Value Sales for Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application for the Years 2015, 2025 & 2030
  • TABLE 107: Europe Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Europe Historic Review for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: Europe 15-Year Perspective for Body Fluid Collection and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Kits & Consumables, Instruments and Other Tests / Services for the Years 2015, 2025 & 2030
• FRANCE
  • Body Fluid Collection and Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 110: France Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: France Historic Review for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: France 15-Year Perspective for Body Fluid Collection and Diagnostics by Sample Type - Percentage Breakdown of Value Sales for Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples for the Years 2015, 2025 & 2030
  • TABLE 113: France Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: France Historic Review for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: France 15-Year Perspective for Body Fluid Collection and Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing for the Years 2015, 2025 & 2030
  • TABLE 116: France Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: France Historic Review for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: France 15-Year Perspective for Body Fluid Collection and Diagnostics by Application - Percentage Breakdown of Value Sales for Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application for the Years 2015, 2025 & 2030
  • TABLE 119: France Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: France Historic Review for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: France 15-Year Perspective for Body Fluid Collection and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Kits & Consumables, Instruments and Other Tests / Services for the Years 2015, 2025 & 2030
• GERMANY
  • Body Fluid Collection and Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 122: Germany Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Germany Historic Review for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: Germany 15-Year Perspective for Body Fluid Collection and Diagnostics by Sample Type - Percentage Breakdown of Value Sales for Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples for the Years 2015, 2025 & 2030
  • TABLE 125: Germany Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Germany Historic Review for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: Germany 15-Year Perspective for Body Fluid Collection and Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing for the Years 2015, 2025 & 2030
  • TABLE 128: Germany Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Germany Historic Review for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: Germany 15-Year Perspective for Body Fluid Collection and Diagnostics by Application - Percentage Breakdown of Value Sales for Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application for the Years 2015, 2025 & 2030
  • TABLE 131: Germany Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Germany Historic Review for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Germany 15-Year Perspective for Body Fluid Collection and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Kits & Consumables, Instruments and Other Tests / Services for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 134: Italy Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Italy Historic Review for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: Italy 15-Year Perspective for Body Fluid Collection and Diagnostics by Sample Type - Percentage Breakdown of Value Sales for Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples for the Years 2015, 2025 & 2030
  • TABLE 137: Italy Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Italy Historic Review for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: Italy 15-Year Perspective for Body Fluid Collection and Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing for the Years 2015, 2025 & 2030
  • TABLE 140: Italy Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Italy Historic Review for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: Italy 15-Year Perspective for Body Fluid Collection and Diagnostics by Application - Percentage Breakdown of Value Sales for Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application for the Years 2015, 2025 & 2030
  • TABLE 143: Italy Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Italy Historic Review for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: Italy 15-Year Perspective for Body Fluid Collection and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Kits & Consumables, Instruments and Other Tests / Services for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Body Fluid Collection and Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 146: UK Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: UK Historic Review for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: UK 15-Year Perspective for Body Fluid Collection and Diagnostics by Sample Type - Percentage Breakdown of Value Sales for Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples for the Years 2015, 2025 & 2030
  • TABLE 149: UK Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: UK Historic Review for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: UK 15-Year Perspective for Body Fluid Collection and Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing for the Years 2015, 2025 & 2030
  • TABLE 152: UK Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: UK Historic Review for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: UK 15-Year Perspective for Body Fluid Collection and Diagnostics by Application - Percentage Breakdown of Value Sales for Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application for the Years 2015, 2025 & 2030
  • TABLE 155: UK Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: UK Historic Review for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: UK 15-Year Perspective for Body Fluid Collection and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Kits & Consumables, Instruments and Other Tests / Services for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 158: Spain Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Spain Historic Review for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Spain 15-Year Perspective for Body Fluid Collection and Diagnostics by Sample Type - Percentage Breakdown of Value Sales for Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples for the Years 2015, 2025 & 2030
  • TABLE 161: Spain Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Spain Historic Review for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: Spain 15-Year Perspective for Body Fluid Collection and Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing for the Years 2015, 2025 & 2030
  • TABLE 164: Spain Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Spain Historic Review for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: Spain 15-Year Perspective for Body Fluid Collection and Diagnostics by Application - Percentage Breakdown of Value Sales for Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application for the Years 2015, 2025 & 2030
  • TABLE 167: Spain Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Spain Historic Review for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: Spain 15-Year Perspective for Body Fluid Collection and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Kits & Consumables, Instruments and Other Tests / Services for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 170: Russia Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Russia Historic Review for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: Russia 15-Year Perspective for Body Fluid Collection and Diagnostics by Sample Type - Percentage Breakdown of Value Sales for Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples for the Years 2015, 2025 & 2030
  • TABLE 173: Russia Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Russia Historic Review for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: Russia 15-Year Perspective for Body Fluid Collection and Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing for the Years 2015, 2025 & 2030
  • TABLE 176: Russia Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Russia Historic Review for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: Russia 15-Year Perspective for Body Fluid Collection and Diagnostics by Application - Percentage Breakdown of Value Sales for Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application for the Years 2015, 2025 & 2030
  • TABLE 179: Russia Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Russia Historic Review for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: Russia 15-Year Perspective for Body Fluid Collection and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Kits & Consumables, Instruments and Other Tests / Services for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 182: Rest of Europe Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Rest of Europe Historic Review for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: Rest of Europe 15-Year Perspective for Body Fluid Collection and Diagnostics by Sample Type - Percentage Breakdown of Value Sales for Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples for the Years 2015, 2025 & 2030
  • TABLE 185: Rest of Europe Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Rest of Europe Historic Review for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: Rest of Europe 15-Year Perspective for Body Fluid Collection and Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing for the Years 2015, 2025 & 2030
  • TABLE 188: Rest of Europe Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Rest of Europe Historic Review for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: Rest of Europe 15-Year Perspective for Body Fluid Collection and Diagnostics by Application - Percentage Breakdown of Value Sales for Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application for the Years 2015, 2025 & 2030
  • TABLE 191: Rest of Europe Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Rest of Europe Historic Review for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: Rest of Europe 15-Year Perspective for Body Fluid Collection and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Kits & Consumables, Instruments and Other Tests / Services for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Body Fluid Collection and Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 194: Asia-Pacific Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 195: Asia-Pacific Historic Review for Body Fluid Collection and Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: Asia-Pacific 15-Year Perspective for Body Fluid Collection and Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 197: Asia-Pacific Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Asia-Pacific Historic Review for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Asia-Pacific 15-Year Perspective for Body Fluid Collection and Diagnostics by Sample Type - Percentage Breakdown of Value Sales for Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples for the Years 2015, 2025 & 2030
  • TABLE 200: Asia-Pacific Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Asia-Pacific Historic Review for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Asia-Pacific 15-Year Perspective for Body Fluid Collection and Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing for the Years 2015, 2025 & 2030
  • TABLE 203: Asia-Pacific Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Asia-Pacific Historic Review for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Asia-Pacific 15-Year Perspective for Body Fluid Collection and Diagnostics by Application - Percentage Breakdown of Value Sales for Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application for the Years 2015, 2025 & 2030
  • TABLE 206: Asia-Pacific Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Asia-Pacific Historic Review for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Asia-Pacific 15-Year Perspective for Body Fluid Collection and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Kits & Consumables, Instruments and Other Tests / Services for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Body Fluid Collection and Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 209: Australia Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Australia Historic Review for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Australia 15-Year Perspective for Body Fluid Collection and Diagnostics by Sample Type - Percentage Breakdown of Value Sales for Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples for the Years 2015, 2025 & 2030
  • TABLE 212: Australia Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Australia Historic Review for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: Australia 15-Year Perspective for Body Fluid Collection and Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing for the Years 2015, 2025 & 2030
  • TABLE 215: Australia Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Australia Historic Review for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: Australia 15-Year Perspective for Body Fluid Collection and Diagnostics by Application - Percentage Breakdown of Value Sales for Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application for the Years 2015, 2025 & 2030
  • TABLE 218: Australia Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Australia Historic Review for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: Australia 15-Year Perspective for Body Fluid Collection and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Kits & Consumables, Instruments and Other Tests / Services for the Years 2015, 2025 & 2030
• INDIA
  • Body Fluid Collection and Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 221: India Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: India Historic Review for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: India 15-Year Perspective for Body Fluid Collection and Diagnostics by Sample Type - Percentage Breakdown of Value Sales for Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples for the Years 2015, 2025 & 2030
  • TABLE 224: India Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: India Historic Review for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: India 15-Year Perspective for Body Fluid Collection and Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing for the Years 2015, 2025 & 2030
  • TABLE 227: India Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: India Historic Review for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: India 15-Year Perspective for Body Fluid Collection and Diagnostics by Application - Percentage Breakdown of Value Sales for Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application for the Years 2015, 2025 & 2030
  • TABLE 230: India Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: India Historic Review for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: India 15-Year Perspective for Body Fluid Collection and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Kits & Consumables, Instruments and Other Tests / Services for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 233: South Korea Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: South Korea Historic Review for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: South Korea 15-Year Perspective for Body Fluid Collection and Diagnostics by Sample Type - Percentage Breakdown of Value Sales for Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples for the Years 2015, 2025 & 2030
  • TABLE 236: South Korea Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: South Korea Historic Review for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: South Korea 15-Year Perspective for Body Fluid Collection and Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing for the Years 2015, 2025 & 2030
  • TABLE 239: South Korea Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: South Korea Historic Review for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: South Korea 15-Year Perspective for Body Fluid Collection and Diagnostics by Application - Percentage Breakdown of Value Sales for Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application for the Years 2015, 2025 & 2030
  • TABLE 242: South Korea Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: South Korea Historic Review for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: South Korea 15-Year Perspective for Body Fluid Collection and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Kits & Consumables, Instruments and Other Tests / Services for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 245: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Asia-Pacific Historic Review for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: Rest of Asia-Pacific 15-Year Perspective for Body Fluid Collection and Diagnostics by Sample Type - Percentage Breakdown of Value Sales for Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples for the Years 2015, 2025 & 2030
  • TABLE 248: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Rest of Asia-Pacific Historic Review for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: Rest of Asia-Pacific 15-Year Perspective for Body Fluid Collection and Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing for the Years 2015, 2025 & 2030
  • TABLE 251: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Rest of Asia-Pacific Historic Review for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Rest of Asia-Pacific 15-Year Perspective for Body Fluid Collection and Diagnostics by Application - Percentage Breakdown of Value Sales for Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application for the Years 2015, 2025 & 2030
  • TABLE 254: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Rest of Asia-Pacific Historic Review for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Rest of Asia-Pacific 15-Year Perspective for Body Fluid Collection and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Kits & Consumables, Instruments and Other Tests / Services for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Body Fluid Collection and Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 257: Latin America Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 258: Latin America Historic Review for Body Fluid Collection and Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Latin America 15-Year Perspective for Body Fluid Collection and Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 260: Latin America Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Latin America Historic Review for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Latin America 15-Year Perspective for Body Fluid Collection and Diagnostics by Sample Type - Percentage Breakdown of Value Sales for Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples for the Years 2015, 2025 & 2030
  • TABLE 263: Latin America Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Latin America Historic Review for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Latin America 15-Year Perspective for Body Fluid Collection and Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing for the Years 2015, 2025 & 2030
  • TABLE 266: Latin America Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Latin America Historic Review for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Latin America 15-Year Perspective for Body Fluid Collection and Diagnostics by Application - Percentage Breakdown of Value Sales for Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application for the Years 2015, 2025 & 2030
  • TABLE 269: Latin America Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Latin America Historic Review for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Latin America 15-Year Perspective for Body Fluid Collection and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Kits & Consumables, Instruments and Other Tests / Services for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 272: Argentina Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Argentina Historic Review for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Argentina 15-Year Perspective for Body Fluid Collection and Diagnostics by Sample Type - Percentage Breakdown of Value Sales for Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples for the Years 2015, 2025 & 2030
  • TABLE 275: Argentina Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Argentina Historic Review for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: Argentina 15-Year Perspective for Body Fluid Collection and Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing for the Years 2015, 2025 & 2030
  • TABLE 278: Argentina Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Argentina Historic Review for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: Argentina 15-Year Perspective for Body Fluid Collection and Diagnostics by Application - Percentage Breakdown of Value Sales for Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application for the Years 2015, 2025 & 2030
  • TABLE 281: Argentina Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Argentina Historic Review for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: Argentina 15-Year Perspective for Body Fluid Collection and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Kits & Consumables, Instruments and Other Tests / Services for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 284: Brazil Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Brazil Historic Review for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: Brazil 15-Year Perspective for Body Fluid Collection and Diagnostics by Sample Type - Percentage Breakdown of Value Sales for Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples for the Years 2015, 2025 & 2030
  • TABLE 287: Brazil Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Brazil Historic Review for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: Brazil 15-Year Perspective for Body Fluid Collection and Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing for the Years 2015, 2025 & 2030
  • TABLE 290: Brazil Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Brazil Historic Review for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: Brazil 15-Year Perspective for Body Fluid Collection and Diagnostics by Application - Percentage Breakdown of Value Sales for Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application for the Years 2015, 2025 & 2030
  • TABLE 293: Brazil Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Brazil Historic Review for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: Brazil 15-Year Perspective for Body Fluid Collection and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Kits & Consumables, Instruments and Other Tests / Services for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 296: Mexico Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Mexico Historic Review for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: Mexico 15-Year Perspective for Body Fluid Collection and Diagnostics by Sample Type - Percentage Breakdown of Value Sales for Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples for the Years 2015, 2025 & 2030
  • TABLE 299: Mexico Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Mexico Historic Review for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: Mexico 15-Year Perspective for Body Fluid Collection and Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing for the Years 2015, 2025 & 2030
  • TABLE 302: Mexico Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Mexico Historic Review for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 304: Mexico 15-Year Perspective for Body Fluid Collection and Diagnostics by Application - Percentage Breakdown of Value Sales for Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application for the Years 2015, 2025 & 2030
  • TABLE 305: Mexico Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Mexico Historic Review for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 307: Mexico 15-Year Perspective for Body Fluid Collection and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Kits & Consumables, Instruments and Other Tests / Services for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 308: Rest of Latin America Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Rest of Latin America Historic Review for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 310: Rest of Latin America 15-Year Perspective for Body Fluid Collection and Diagnostics by Sample Type - Percentage Breakdown of Value Sales for Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples for the Years 2015, 2025 & 2030
  • TABLE 311: Rest of Latin America Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Rest of Latin America Historic Review for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 313: Rest of Latin America 15-Year Perspective for Body Fluid Collection and Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing for the Years 2015, 2025 & 2030
  • TABLE 314: Rest of Latin America Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Rest of Latin America Historic Review for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 316: Rest of Latin America 15-Year Perspective for Body Fluid Collection and Diagnostics by Application - Percentage Breakdown of Value Sales for Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application for the Years 2015, 2025 & 2030
  • TABLE 317: Rest of Latin America Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 318: Rest of Latin America Historic Review for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 319: Rest of Latin America 15-Year Perspective for Body Fluid Collection and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Kits & Consumables, Instruments and Other Tests / Services for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Body Fluid Collection and Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 320: Middle East Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 321: Middle East Historic Review for Body Fluid Collection and Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 322: Middle East 15-Year Perspective for Body Fluid Collection and Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 323: Middle East Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 324: Middle East Historic Review for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 325: Middle East 15-Year Perspective for Body Fluid Collection and Diagnostics by Sample Type - Percentage Breakdown of Value Sales for Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples for the Years 2015, 2025 & 2030
  • TABLE 326: Middle East Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 327: Middle East Historic Review for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 328: Middle East 15-Year Perspective for Body Fluid Collection and Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing for the Years 2015, 2025 & 2030
  • TABLE 329: Middle East Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 330: Middle East Historic Review for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 331: Middle East 15-Year Perspective for Body Fluid Collection and Diagnostics by Application - Percentage Breakdown of Value Sales for Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application for the Years 2015, 2025 & 2030
  • TABLE 332: Middle East Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 333: Middle East Historic Review for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 334: Middle East 15-Year Perspective for Body Fluid Collection and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Kits & Consumables, Instruments and Other Tests / Services for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 335: Iran Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 336: Iran Historic Review for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 337: Iran 15-Year Perspective for Body Fluid Collection and Diagnostics by Sample Type - Percentage Breakdown of Value Sales for Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples for the Years 2015, 2025 & 2030
  • TABLE 338: Iran Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 339: Iran Historic Review for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 340: Iran 15-Year Perspective for Body Fluid Collection and Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing for the Years 2015, 2025 & 2030
  • TABLE 341: Iran Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 342: Iran Historic Review for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 343: Iran 15-Year Perspective for Body Fluid Collection and Diagnostics by Application - Percentage Breakdown of Value Sales for Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application for the Years 2015, 2025 & 2030
  • TABLE 344: Iran Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 345: Iran Historic Review for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 346: Iran 15-Year Perspective for Body Fluid Collection and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Kits & Consumables, Instruments and Other Tests / Services for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 347: Israel Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 348: Israel Historic Review for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 349: Israel 15-Year Perspective for Body Fluid Collection and Diagnostics by Sample Type - Percentage Breakdown of Value Sales for Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples for the Years 2015, 2025 & 2030
  • TABLE 350: Israel Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 351: Israel Historic Review for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 352: Israel 15-Year Perspective for Body Fluid Collection and Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing for the Years 2015, 2025 & 2030
  • TABLE 353: Israel Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 354: Israel Historic Review for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 355: Israel 15-Year Perspective for Body Fluid Collection and Diagnostics by Application - Percentage Breakdown of Value Sales for Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application for the Years 2015, 2025 & 2030
  • TABLE 356: Israel Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 357: Israel Historic Review for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 358: Israel 15-Year Perspective for Body Fluid Collection and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Kits & Consumables, Instruments and Other Tests / Services for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 359: Saudi Arabia Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 360: Saudi Arabia Historic Review for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 361: Saudi Arabia 15-Year Perspective for Body Fluid Collection and Diagnostics by Sample Type - Percentage Breakdown of Value Sales for Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples for the Years 2015, 2025 & 2030
  • TABLE 362: Saudi Arabia Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 363: Saudi Arabia Historic Review for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 364: Saudi Arabia 15-Year Perspective for Body Fluid Collection and Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing for the Years 2015, 2025 & 2030
  • TABLE 365: Saudi Arabia Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 366: Saudi Arabia Historic Review for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 367: Saudi Arabia 15-Year Perspective for Body Fluid Collection and Diagnostics by Application - Percentage Breakdown of Value Sales for Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application for the Years 2015, 2025 & 2030
  • TABLE 368: Saudi Arabia Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 369: Saudi Arabia Historic Review for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 370: Saudi Arabia 15-Year Perspective for Body Fluid Collection and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Kits & Consumables, Instruments and Other Tests / Services for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 371: UAE Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 372: UAE Historic Review for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 373: UAE 15-Year Perspective for Body Fluid Collection and Diagnostics by Sample Type - Percentage Breakdown of Value Sales for Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples for the Years 2015, 2025 & 2030
  • TABLE 374: UAE Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 375: UAE Historic Review for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 376: UAE 15-Year Perspective for Body Fluid Collection and Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing for the Years 2015, 2025 & 2030
  • TABLE 377: UAE Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 378: UAE Historic Review for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 379: UAE 15-Year Perspective for Body Fluid Collection and Diagnostics by Application - Percentage Breakdown of Value Sales for Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application for the Years 2015, 2025 & 2030
  • TABLE 380: UAE Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 381: UAE Historic Review for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 382: UAE 15-Year Perspective for Body Fluid Collection and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Kits & Consumables, Instruments and Other Tests / Services for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 383: Rest of Middle East Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 384: Rest of Middle East Historic Review for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 385: Rest of Middle East 15-Year Perspective for Body Fluid Collection and Diagnostics by Sample Type - Percentage Breakdown of Value Sales for Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples for the Years 2015, 2025 & 2030
  • TABLE 386: Rest of Middle East Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 387: Rest of Middle East Historic Review for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 388: Rest of Middle East 15-Year Perspective for Body Fluid Collection and Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing for the Years 2015, 2025 & 2030
  • TABLE 389: Rest of Middle East Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 390: Rest of Middle East Historic Review for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 391: Rest of Middle East 15-Year Perspective for Body Fluid Collection and Diagnostics by Application - Percentage Breakdown of Value Sales for Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application for the Years 2015, 2025 & 2030
  • TABLE 392: Rest of Middle East Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 393: Rest of Middle East Historic Review for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 394: Rest of Middle East 15-Year Perspective for Body Fluid Collection and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Kits & Consumables, Instruments and Other Tests / Services for the Years 2015, 2025 & 2030
• AFRICA
  • Body Fluid Collection and Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 395: Africa Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 396: Africa Historic Review for Body Fluid Collection and Diagnostics by Sample Type - Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 397: Africa 15-Year Perspective for Body Fluid Collection and Diagnostics by Sample Type - Percentage Breakdown of Value Sales for Blood Samples, Saliva Samples, Urine Samples and Cerebrospinal Fluid Samples for the Years 2015, 2025 & 2030
  • TABLE 398: Africa Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 399: Africa Historic Review for Body Fluid Collection and Diagnostics by Technology Type - Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 400: Africa 15-Year Perspective for Body Fluid Collection and Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Fluorescence In situ Hybridization, Other Technologies, Polymerase Chain Reaction and Next Generation Sequencing for the Years 2015, 2025 & 2030
  • TABLE 401: Africa Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 402: Africa Historic Review for Body Fluid Collection and Diagnostics by Application - Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 403: Africa 15-Year Perspective for Body Fluid Collection and Diagnostics by Application - Percentage Breakdown of Value Sales for Diagnostics & Monitoring Application, Therapeutic Decision Making Application and Prognostics & Screening Application for the Years 2015, 2025 & 2030
  • TABLE 404: Africa Recent Past, Current & Future Analysis for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 405: Africa Historic Review for Body Fluid Collection and Diagnostics by Product Type - Kits & Consumables, Instruments and Other Tests / Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 406: Africa 15-Year Perspective for Body Fluid Collection and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Kits & Consumables, Instruments and Other Tests / Services for the Years 2015, 2025 & 2030

IV. COMPETITION